Iida Madoka, Sahashi Kentaro, Hirunagi Tomoki, Sakakibara Kenji, Maeda Kentaro, Iguchi Yohei, Li Jiayi, Ogura Yosuke, Iizuka Masaki, Akashi Tomohiro, Hinohara Kunihiko, Sugio Shouta, Wake Hiroaki, Nakatochi Masahiro, Katsuno Masahisa
Department of Neurology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Aichi, Japan.
Nagoya University Institute for Advanced Research, Furo-cho, Chikusa-ku, Nagoya, Aichi, Japan.
JCI Insight. 2025 Jun 23;10(12). doi: 10.1172/jci.insight.182123.
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by an expanded CAG repeat in the androgen receptor (AR) gene. To elucidate the cell type-specific temporal gene expression in SBMA, we performed single-nucleus RNA sequencing on the spinal cords of an SBMA mouse model (AR-97Q). Among all cell types, oligodendrocytes had the highest number of differentially expressed genes before disease onset. Analysis of oligodendrocyte clusters suggested that pathways associated with cation channels and synaptic function were activated before disease onset, with increased output from oligodendrocytes to neurons in AR-97Q mice compared with wild-type mice. These changes in the early stages were abrogated at the advanced stages. An oligodendrocyte model of SBMA showed phenotypes similar to those of AR-97Q mice at early stages, such as increased transcriptional changes in synapse organization, and Ca2+ imaging of oligodendrocytes in AR-97Q mice revealed the increased Ca2+ responses. A coculture system of primary rat oligodendrocytes and neurons revealed that the mutant AR in oligodendrocytes affected the activity and synchronization of neurons. These findings suggest that dysregulated cell-to-cell communication plays a critical role in early SBMA pathology and that synaptic or ion channel-related proteins, such as contactin associated protein 2 (Cntnap2) and NALCN channel auxiliary factor 1 (Fam155a), are potential therapeutic targets for SBMA.
脊髓延髓性肌萎缩症(SBMA)是一种由雄激素受体(AR)基因中CAG重复序列扩增引起的神经肌肉疾病。为了阐明SBMA中细胞类型特异性的时间基因表达情况,我们对SBMA小鼠模型(AR-97Q)的脊髓进行了单核RNA测序。在所有细胞类型中,少突胶质细胞在疾病发作前差异表达基因的数量最多。对少突胶质细胞簇的分析表明,与阳离子通道和突触功能相关的通路在疾病发作前被激活,与野生型小鼠相比,AR-97Q小鼠中少突胶质细胞向神经元的输出增加。这些早期变化在晚期阶段被消除。SBMA的少突胶质细胞模型在早期阶段表现出与AR-97Q小鼠相似的表型,如突触组织中转录变化增加,AR-97Q小鼠少突胶质细胞的Ca2+成像显示Ca2+反应增加。原代大鼠少突胶质细胞和神经元的共培养系统表明,少突胶质细胞中的突变AR影响神经元的活性和同步性。这些发现表明,细胞间通讯失调在早期SBMA病理学中起关键作用,并且突触或离子通道相关蛋白,如接触蛋白相关蛋白2(Cntnap2)和NALCN通道辅助因子1(Fam155a),是SBMA的潜在治疗靶点。